French biotech Pharnext has seen the value of its shares collapse after it revealed that its lead drug, a treatment for Charcot-Marie-Tooth (CMT) disease, failed to make the grade in a phase 3 trial.

After decades of stagnation in the drug treatment of schizophrenia, a handful of new therapies have raised hopes of improvement – but one of them has just failed a pair of phase 3 trials. Sumitomo ...

To play Globle, you’re first going to have to access the game’s website. To start playing, simply enter in the name of any country of your choice. You’ll then get a colour match for that country ...